Roche announced that the Swiss agency for the authorisation and supervision of therapeutic products (Swissmedic) has granted authorisation of Ocrevus (ocrelizumab) for the treatment of adult patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results